Topical administration of leukotriene antagonists in immunogenic keratitis.

Antagonists of leukotriene D4 (LTD4), 3-[7-(2-n-propyl-3-hydroxy-4-acetyl-phenoxy)-propoxy-2-methyl-3,4-dihydro-4-8- n-propyl-2H-1 -benzopyran-2-yl]-propionic acid (SC-39070) and